Close

Mr Elliot McClenaghan

BSc MPH

Research Fellow
in Epidemiology

Room
G10

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I joined the department of Infectious Disease Epidemiology at LSHTM in November 2021. Previously I worked as a medical statistician at the UK Cystic Fibrosis Registry, where I designed and conducted post-authorisation drug safety studies and was lead statistician on a global registry collaboration on the impact of COVID-19 in people with cystic fibrosis. I studied Biomedical Sciences at Newcastle University and obtained an MPH in Public Health with a strong quantitative focus at Queen’s University Belfast.

Affiliations

Faculty of Epidemiology and Population Health
Department of Infectious Disease Epidemiology

Centres

Vaccine Centre

Teaching

I teach on the following MSc modules; Statistical Methods in Epidemiology and Advanced Statistical Methods in Epidemiology. I also teach on the Professional Certificate in Pharmacoepidemiology and Pharmacovigilance short course.

Research

My current research focuses on vaccine effectiveness, clinical data linkage and epidemiology of COVID-19. I support the coronavirus school infection survey collaboration as well as a project investigating non-specific effects of vaccination in people with cystic fibrosis. My previous research has included pharmacoepidemiology, cystic fibrosis, global health and registry-based studies. As a member of the board of trustees of a small non-profit, Share Uganda, I support monitoring and evaluation, data collection and research activities relating to the charity’s public health programmes in collaboration with local stakeholders in Uganda.

Research Area
Clinical databases
Pharmacovigilance
Public health
Statistical methods
Vaccines
Viruses
Electronic health records
Global Health
Discipline
Pharmacoepidemiology
Epidemiology
Statistics
Disease and Health Conditions
Infectious disease
Respiratory disease
Coronavirus
Country
United Kingdom
Uganda

Selected Publications

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Carr SB; McClenaghan E; Elbert A; Faro A; Cosgriff R; Abdrakhmanov O; Brownlee K; Burgel P-R; Byrnes CA; Cheng SY
2022
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Carr SB; Cosgriff R; Harutyunyan S; Middleton PG; Ruseckaite R; Ahern S; Daneau G; Filho LVRFDS; Stephenson AL; Cheng SY
2021
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel P-R; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G
2021
Journal of Cystic Fibrosis
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tjesic-Drinkovic D
2021
JOURNAL OF CYSTIC FIBROSIS
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel P-R; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G
2020
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
What Predicts Hospital Admissions in Community-Dwelling People With Parkinsonism?
Sebastian R; Gray WK; Foley A; Trendall L; Oh D; Hand A; Dodds S; McClenaghan E; Santos VD; Oates LL
2019
Journal of geriatric psychiatry and neurology
Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry.
Gardner AI; McClenaghan E; Saint G; McNamara PS; Brodlie M; Thomas MF
2018
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
See more Publications